Pharvaris director files notice to sell 800 shares

A Pharvaris N.V. director filed a Rule 144 notice to sell 800 shares from option exercises, following several earlier share sales in the prior three months.

Rhea-AI Filing Summary

Pharvaris N.V. (PHVS) director Johannes Gerardus Christiaan Petrus Schikan filed a notice of proposed sale of Pharvaris common shares under Rule 144. The filing indicates an intent to sell 800 common shares on September 22, 2026, to be acquired through the exercise of options under a registered plan for cash.

The notice also lists prior sales of Pharvaris common stock by the same person during the preceding three months, including transactions on June 29, June 30, and September 17, 2026, each reporting share amounts and aggregate proceeds.

Key Figures

Proposed shares to be sold: 800 shares Aggregate market value for proposed sale: $28,952.00 Sale on September 17, 2026: 200,000 shares; $7,000,000.00 +3 more

6 metrics

Proposed shares to be sold 800 shares Common stock sale proposed for September 22, 2026 under Rule 144

Aggregate market value for proposed sale $28,952.00 Securities information for 800 Pharvaris common shares

Sale on September 17, 2026 200,000 shares; $7,000,000.00 Past 3 months sales of Pharvaris common stock

Sale on June 30, 2026 30,721 shares; $1,090,048.73 Past 3 months sales of Pharvaris common stock

Sale on June 29, 2026 (larger trade) 6,888 shares; $241,424.40 Past 3 months sales of Pharvaris common stock

Sale on June 29, 2026 (smaller trade) 2,400 shares; $84,240.00 Additional past 3 months sale of Pharvaris common stock

Key Terms

Rule 144, Form 144, Exercise of Options Under a Registered Plan

3 terms

Rule 144 regulatory

"See the definition of "person" in paragraph (a) of Rule 144."

Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.

Form 144 regulatory

"144: Filer Information"

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

Exercise of Options Under a Registered Plan financial

"Common | 09/22/2026 | Exercise of Options Under a Registered Plan"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the Form 144 filing disclose for Pharvaris N.V. (PHVS)?

The Form 144 discloses that director Johannes Gerardus Christiaan Petrus Schikan has filed a notice of proposed sale of 800 shares of Pharvaris N.V. common stock, to be sold on September 22, 2026 after exercising options under a registered plan.

How many Pharvaris (PHVS) shares are proposed to be sold in this Form 144?

The filing states that 800 shares of Pharvaris N.V. common stock are proposed to be sold. These shares are to be acquired through the exercise of options under a registered plan and sold for cash on September 22, 2026.

What recent Pharvaris (PHVS) share sales by the filer are reported?

The notice reports prior sales of Pharvaris common stock in the past three months, including 200,000 shares sold on September 17, 2026, 30,721 shares sold on June 30, 2026, and additional trades of 6,888 and 2,400 shares on June 29, 2026.

Who is selling Pharvaris (PHVS) shares in this Form 144?

The seller is Johannes Gerardus Christiaan Petrus Schikan, identified as a director of Pharvaris N.V. He is the person for whose account the securities are to be sold, as reported in the Form 144 notice.

On which market are the Pharvaris (PHVS) shares in the Form 144 expected to trade?

The securities information section identifies the common stock as traded on NASDAQ. The proposed sale of 800 Pharvaris N.V. common shares under the Form 144 is tied to that listing.

What is the role of Morgan Stanley Smith Barney LLC in this Pharvaris (PHVS) Form 144?

Morgan Stanley Smith Barney LLC Executive Financial Services is listed in the securities information section in connection with the 800-share proposed sale of Pharvaris common stock, indicating its involvement in handling the transaction.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 09/22/2026 - 04:14 PM Accepted by SEC EDGAR 09/22/2026 - 04:13 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0002014983
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	PHARVARIS N.V.
SEC File Number	001-40010
Address of Issuer	Emmy Noetherweg 2 Leiden NETHERLANDS 2333 BK
Phone	31 (0)71 2036 410
Name of Person for Whose Account the Securities are To Be Sold	JOHANNES GER. CHRIS. PE SCHIKAN
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Director

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	800	28952.00	65210590	09/22/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	09/22/2026	Exercise of Options Under a Registered Plan	Issuer			800	09/22/2026	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
JOHANNES GER. CHRIS. PE SCHIKAN Emmy Noetherweg 2 Leiden P7 2333 BK	Common	09/17/2026	200000	7000000.00
JOHANNES GER. CHRIS. PE SCHIKAN Emmy Noetherweg 2 Leiden P7 2333 BK	Common	06/30/2026	30721	1090048.73
JOHANNES GER. CHRIS. PE SCHIKAN Emmy Noetherweg 2 Leiden P7 2333 BK	Common	06/29/2026	6888	241424.40
JOHANNES GER. CHRIS. PE SCHIKAN Emmy Noetherweg 2 Leiden P7 2333 BK	Common	06/29/2026	2400	84240.00

144: Remarks and Signature

Remarks
Date of Notice	09/22/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Johannes Gerardus Christiaan Petrus Schikan
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)